Featured Research

from universities, journals, and other organizations

Shock teams and ECMO save lives in massive STEMI

Date:
March 11, 2013
Source:
Minneapolis Heart Institute Foundation
Summary:
The use of extracorporeal membrane oxygenation, accompanied by mechanical CPR, in patients with massive myocardial infarctions can lead to unexpected survival. ECMO is an advanced technology that functions as a replacement for a critically ill patient's heart and lungs. This is the first report of combined ECMO, mechanical CPR and therapeutic hypothermia use within a STEMI Network.

The use of extracorporeal membrane oxygenation (ECMO), accompanied by mechanical CPR, in patients with massive myocardial infarctions can lead to unexpected survival. These study findings are being presented March 9 at the American College of Cardiology Scientific Sessions.

Related Articles


ECMO is an advanced technology that functions as a replacement for a critically ill patient's heart and lungs. This is the first report of combined ECMO, mechanical CPR and therapeutic hypothermia (TH) use within a STEMI Network.

"For many patients who present with a severe heart attack, or ST-elevation myocardial infarction (STEMI), complicated by cardiogenic shock that progresses to cardiac standstill, the result is almost uniformly fatal," says Michael R. Mooney, MD, a research cardiologist at the Minneapolis Heart Institute Foundation (MHIF) and a physician at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis. "This aggressive approach despite its complexity extends our ability to salvage the most devastating complication of acute MI."

The patients in this study were a consecutive series with STEMI meeting criteria for ECMO from August 2011 to October 2012. The Shock Team composed of a perfusionist, an advanced heart failure cardiologist, an interventional cardiologist and a cardiac surgeon developed a protocol and a process for emergency ECMO (E-ECMO) in the CV lab. This same team was then used to implement E-ECMO.

The study included five patients (three males) with a median age of 64 years. The median time of cardiac arrest from the initiation of ECMO was 52 minutes, and ECMO was required for a median time of 4 days in these patients. After ECMO was initiated, therapeutic hypothermia was used in 4 of the cases. Mechanical CPR devices were used in all cases.

Of the five patients, four survived to hospital discharge and all of the survivors had "good neurologic recovery at discharge," Mooney reports. Of the four survivors, discharge ejection fraction improved from 0-10% to a median of 45%. Blood transfusions were required in all cases.

This group of patients account for nearly half of all deaths within a STEMI network and no effective treatment was previously available. "ECMO, along with mechanical CPR, and TH can provide survival in situations previously regarded as uniformly fatal. Therefore, ECMO may have a role in selected PCI centers with advanced specialized teams with the appropriate experience," stated Mooney.


Story Source:

The above story is based on materials provided by Minneapolis Heart Institute Foundation. Note: Materials may be edited for content and length.


Cite This Page:

Minneapolis Heart Institute Foundation. "Shock teams and ECMO save lives in massive STEMI." ScienceDaily. ScienceDaily, 11 March 2013. <www.sciencedaily.com/releases/2013/03/130311101825.htm>.
Minneapolis Heart Institute Foundation. (2013, March 11). Shock teams and ECMO save lives in massive STEMI. ScienceDaily. Retrieved March 28, 2015 from www.sciencedaily.com/releases/2013/03/130311101825.htm
Minneapolis Heart Institute Foundation. "Shock teams and ECMO save lives in massive STEMI." ScienceDaily. www.sciencedaily.com/releases/2013/03/130311101825.htm (accessed March 28, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, March 28, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins